136 results
8-K
EX-99.1
ctrcfbqvuu00v4d
2 Dec 22
Other Events
8:13am
S-3ASR
7woxag
24 Sep 21
Automatic shelf registration
5:04pm
8-K
EX-10.2
qvtlc9i05ex42dd7
24 Jun 21
Anavex Life Sciences Announces $50 Million Registered Direct Offering
4:21pm
424B5
qxr0vr09u0mxfym6bq4
24 Jun 21
Prospectus supplement for primary offering
8:46am
424B5
gsbrclqfw9y gu4qvnby
16 Feb 21
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
q3z g53uyfeofu8gq9pz
28 Dec 20
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results
5:28pm
8-K
EX-99.1
uo6c6b5
15 Dec 20
Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I
7:06am